CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 148 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,906,455 | +310.7% | 798,555 | +201.6% | 0.00% | +200.0% |
| Q2 2023 | $2,898,837 | +763.9% | 264,734 | +588.0% | 0.00% | – |
| Q1 2023 | $335,546 | +54.8% | 38,480 | +11.3% | 0.00% | – |
| Q4 2022 | $216,729 | +79.1% | 34,566 | 0.0% | 0.00% | – |
| Q3 2022 | $121,000 | -16.0% | 34,566 | -28.9% | 0.00% | – |
| Q2 2022 | $144,000 | -80.6% | 48,612 | -79.7% | 0.00% | – |
| Q1 2022 | $744,000 | +22.2% | 239,215 | +32.9% | 0.00% | – |
| Q4 2021 | $609,000 | -4.1% | 179,959 | +3.4% | 0.00% | – |
| Q3 2021 | $635,000 | -72.6% | 173,959 | -67.3% | 0.00% | -100.0% |
| Q2 2021 | $2,317,000 | -5.4% | 531,334 | -1.4% | 0.00% | 0.0% |
| Q1 2021 | $2,448,000 | -18.0% | 539,114 | +3.7% | 0.00% | 0.0% |
| Q4 2020 | $2,984,000 | -20.8% | 519,693 | -0.1% | 0.00% | -50.0% |
| Q3 2020 | $3,768,000 | +147.6% | 520,418 | +19.4% | 0.00% | +100.0% |
| Q2 2020 | $1,522,000 | +173.7% | 435,930 | +16.2% | 0.00% | – |
| Q1 2020 | $556,000 | -23.3% | 375,265 | +1.5% | 0.00% | – |
| Q4 2019 | $725,000 | -63.8% | 369,704 | -5.5% | 0.00% | -100.0% |
| Q3 2019 | $2,003,000 | -28.8% | 391,098 | -0.5% | 0.00% | -50.0% |
| Q2 2019 | $2,815,000 | -41.9% | 393,123 | +7.7% | 0.00% | -33.3% |
| Q1 2019 | $4,847,000 | +90.3% | 364,918 | +12.8% | 0.00% | +50.0% |
| Q4 2018 | $2,547,000 | -29.4% | 323,599 | -0.6% | 0.00% | 0.0% |
| Q3 2018 | $3,609,000 | +106.6% | 325,651 | +150.2% | 0.00% | +100.0% |
| Q2 2018 | $1,747,000 | +559.2% | 130,165 | +539.2% | 0.00% | – |
| Q1 2018 | $265,000 | +130.4% | 20,365 | +63.4% | 0.00% | – |
| Q4 2017 | $115,000 | – | 12,465 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,653,495 | $10,367,414 | 8.97% |
| Versant Venture Management, LLC | 543,753 | $3,409,330 | 7.06% |
| TCG Crossover Management, LLC | 5,905,400 | $37,026,858 | 6.54% |
| COMMODORE CAPITAL LP | 5,738,500 | $35,980 | 5.42% |
| Foresite Capital Management IV, LLC | 1,787,094 | $11,205,079 | 4.79% |
| Saturn V Capital Management LP | 1,611,778 | $5,718,432 | 4.74% |
| ACUTA CAPITAL PARTNERS, LLC | 1,015,000 | $6,364,050 | 3.92% |
| Altium Capital Management LP | 1,025,000 | $6,426,750 | 3.27% |
| Affinity Asset Advisors, LLC | 1,143,531 | $7,169,939 | 2.81% |
| GREAT POINT PARTNERS LLC | 1,550,000 | $9,718,500 | 1.90% |